|Download document||Draft concept paper on review and update of European Medicines Agency guidelines to implement best practice with regard to 3Rs (replacement, reduction and refinement) in regulatory testing of medicinal products|
|Status||draft: consultation open|
|Consultation start date||07/02/2014|
|Consultation end date||31/05/2014|
|Email address for firstname.lastname@example.org|
The Joint CHMP/CVMP ad-hoc expert group on the application of the 3Rs in the regulatory testing of medicinal products (JEG 3Rs), in coordination with relevant CHMP and CVMP working parties, has been reviewing existing European Medicines Agency guidance documents with a view to ensuring that these reflect current best practice with regard to implementation of 3Rs approaches.